Sutherland FR - Search Results

1

Identification of prognostic inflammatory factors in colorectal liver metastases.

Hamilton TD, Leugner D, Kopciuk K, Dixon E, Sutherland FR, Bathe OF. Hamilton TD, et al. Among authors: sutherland fr. BMC Cancer. 2014 Jul 28;14:542. doi: 10.1186/1471-2407-14-542. BMC Cancer. 2014. PMID: 25069793 Free PMC article.

2

Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.

Bathe OF, Dowden S, Sutherland F, Dixon E, Butts C, Bigam D, Walley B, Ruether D, Ernst S. Bathe OF, et al. BMC Cancer. 2004 Jul 10;4:32. doi: 10.1186/1471-2407-4-32. BMC Cancer. 2004. PMID: 15245580 Free PMC article. Clinical Trial.

3

Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study.

Ng JK, Urbanski SJ, Mangat N, McKay A, Sutherland FR, Dixon E, Dowden S, Ernst S, Bathe OF. Ng JK, et al. Among authors: sutherland fr. Cancer. 2008 Jan 15;112(2):362-71. doi: 10.1002/cncr.23184. Cancer. 2008. PMID: 18041069 Free article.

4

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.

Bathe OF, Ernst S, Sutherland FR, Dixon E, Butts C, Bigam D, Holland D, Porter GA, Koppel J, Dowden S. Bathe OF, et al. Among authors: sutherland fr. BMC Cancer. 2009 May 20;9:156. doi: 10.1186/1471-2407-9-156. BMC Cancer. 2009. PMID: 19457245 Free PMC article. Clinical Trial.

5

Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases.

van Dijk DPJ, Krill M, Farshidfar F, Li T, Rensen SS, Olde Damink SWM, Dixon E, Sutherland FR, Ball CG, Mazurak VC, Baracos VE, Bathe OF. van Dijk DPJ, et al. Among authors: sutherland fr. J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):123-130. doi: 10.1002/jcsm.12358. Epub 2018 Oct 31. J Cachexia Sarcopenia Muscle. 2019. PMID: 30378742 Free PMC article.

6

Vascular occlusion to decrease blood loss during hepatic resection.

Dixon E, Vollmer CM Jr, Bathe OF, Sutherland F. Dixon E, et al. Am J Surg. 2005 Jul;190(1):75-86. doi: 10.1016/j.amjsurg.2004.10.007. Am J Surg. 2005. PMID: 15972177 Review.

7

Complex hepatic surgery aided by a 1.5-tesla moveable magnetic resonance imaging system.

Bathe OF, Mahallati H, Sutherland F, Dixon E, Pasieka J, Sutherland G. Bathe OF, et al. Am J Surg. 2006 May;191(5):598-603. doi: 10.1016/j.amjsurg.2006.02.008. Am J Surg. 2006. PMID: 16647344

8

Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients.

Schieman C, Rudmik LR, Dixon E, Sutherland F, Bathe OF. Schieman C, et al. Can J Surg. 2009 Oct;52(5):422-6. Can J Surg. 2009. PMID: 19865579 Free PMC article.

9

Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery.

McKay A, Sutherland FR, Bathe OF, Dixon E. McKay A, et al. Among authors: sutherland fr. J Gastrointest Surg. 2008 Jan;12(1):86-90. doi: 10.1007/s11605-007-0273-1. Epub 2007 Aug 21. J Gastrointest Surg. 2008. PMID: 17710505

10

Feasibility of identifying pancreatic cancer based on serum metabolomics.

Bathe OF, Shaykhutdinov R, Kopciuk K, Weljie AM, McKay A, Sutherland FR, Dixon E, Dunse N, Sotiropoulos D, Vogel HJ. Bathe OF, et al. Among authors: sutherland fr. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):140-7. doi: 10.1158/1055-9965.EPI-10-0712. Epub 2010 Nov 23. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21098649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page